Massard C - Search Results

1

Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.

Al Nakouzi N, Le Moulec S, Albigès L, Wang C, Beuzeboc P, Gross-Goupil M, de La Motte Rouge T, Guillot A, Gajda D, Massard C, Gleave M, Fizazi K, Loriot Y. Al Nakouzi N, et al. Among authors: massard c. Eur Urol. 2015 Aug;68(2):228-35. doi: 10.1016/j.eururo.2014.04.015. Epub 2014 May 2. Eur Urol. 2015. PMID: 24837187

2

[Cannabis and cancer].

Vignot S, Besse B, de la Motte Rouge T, Massard C, Spano JP, Karila L. Vignot S, et al. Among authors: massard c. Bull Cancer. 2006 Feb;93(2):163-70. Bull Cancer. 2006. PMID: 16517414 Free article. Review. French.

3

Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.

Loriot Y, Perlemuter G, Malka D, Penault-Llorca F, Boige V, Deutsch E, Massard C, Armand JP, Soria JC. Loriot Y, et al. Among authors: massard c. Nat Clin Pract Oncol. 2008 May;5(5):268-78. doi: 10.1038/ncponc1087. Epub 2008 Mar 18. Nat Clin Pract Oncol. 2008. PMID: 18349858 Review.

4

Wound healing delay after central venous access following DCF/VEGF-trap therapy.

Ferté C, Massard C, Moldovan C, Desruennes E, Loriot Y, Soria JC. Ferté C, et al. Among authors: massard c. Invest New Drugs. 2009 Dec;27(6):583-5. doi: 10.1007/s10637-009-9227-7. Epub 2009 Feb 17. Invest New Drugs. 2009. PMID: 19221694

5

Phase II trial of consolidation docetaxel and samarium-153 in patients with bone metastases from castration-resistant prostate cancer.

Fizazi K, Beuzeboc P, Lumbroso J, Haddad V, Massard C, Gross-Goupil M, Di Palma M, Escudier B, Theodore C, Loriot Y, Tournay E, Bouzy J, Laplanche A. Fizazi K, et al. Among authors: massard c. J Clin Oncol. 2009 May 20;27(15):2429-35. doi: 10.1200/JCO.2008.18.9811. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364971 Clinical Trial.

6

Sequential therapy in renal cell carcinoma.

Escudier B, Goupil MG, Massard C, Fizazi K. Escudier B, et al. Among authors: massard c. Cancer. 2009 May 15;115(10 Suppl):2321-6. doi: 10.1002/cncr.24241. Cancer. 2009. PMID: 19402067 Free article. Review.

7

Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma.

Michels J, Lassau N, Gross-Goupil M, Massard C, Mejean A, Escudier B. Michels J, et al. Among authors: massard c. Invest New Drugs. 2010 Oct;28(5):690-3. doi: 10.1007/s10637-009-9275-z. Epub 2009 Jun 24. Invest New Drugs. 2010. PMID: 19547920

8

Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with everolimus.

Massard C, Fizazi K, Gross-Goupil M, Escudier B. Massard C, et al. Invest New Drugs. 2010 Dec;28(6):879-81. doi: 10.1007/s10637-009-9295-8. Epub 2009 Aug 1. Invest New Drugs. 2010. PMID: 19649567 No abstract available.

9

New agents in metastatic prostate cancer.

Fizazi K, Massard C. Fizazi K, et al. Among authors: massard c. Eur J Cancer. 2009 Sep;45 Suppl 1:379-80. doi: 10.1016/S0959-8049(09)70056-5. Eur J Cancer. 2009. PMID: 19775638 No abstract available.

10

[Prostate tumors].

Massard C, Fizazi K. Massard C, et al. Rev Prat. 2010 Jan 20;60(1):113-9. Rev Prat. 2010. PMID: 20222324 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters